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Mutations in rumi result in a temperature-sensitive loss of Notch
signaling in Drosophila. Drosophila Rumi is a soluble, endoplasmic
reticulum-retained protein with a CAP10 domain that functions as
a protein O-glucosyltransferase. In human and mouse genomes,
three potential Rumi homologues exist: one with a high degree
of identity to Drosophila Rumi (52%), and two others with lower
degrees of identity but including a CAP10 domain (KDELC1 and
KDELC2). Here we show that both mouse and human Rumi, but
not KDELC1 or KDELC2, catalyze transfer of glucose from UDPglucose to an EGF repeat from human factor VII. Similarly, human
Rumi, but not KDELC1 or KDELC2, rescues the Notch phenotypes in
Drosophila rumi clones. During characterization of the Rumi enzymes, we noted that, in addition to protein O-glucosyltransferase
activity, both mammalian and Drosophila Rumi also showed
significant protein O-xylosyltransferase activity. Rumi transfers
Xyl or glucose to serine 52 in the O-glucose consensus sequence
(50 CASSPC55 ) of factor VII EGF repeat. Surprisingly, the second
serine (S53) facilitates transfer of Xyl, but not glucose, to the EGF
repeat by Rumi. EGF16 of mouse Notch2, which has a diserine motif
in the consensus sequence (587 CYSSPC592 ), is also modified with
either O-Xyl or O-glucose glycans in cells. Mutation of the second
serine (S590A) causes a loss of O-Xyl but not O-glucose at this
site. Altogether, our data establish dual substrate specificity for
the glycosyltransferase Rumi and provide evidence that amino
acid sequences of the recipient EGF repeat significantly influence
which donor substrate (UDP-glucose or UDP-Xyl) is used.
development ∣ glycobiology ∣ mass spectrometry
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T

he Notch signaling pathway plays a central role in developmental processes throughout the animal kingdom, controlling
cell fate decisions in numerous tissues (1, 2). Its diverse functions
are reflected in the wide range of human diseases linked to defects in the pathway, including Alagille syndrome, spondylocostal
dysostosis, cerebral autosomal dominat arteriopathy with subcortical infarcts and leukoencephalopathy, multiple sclerosis, and
several types of cancers (3). The extracellular domains of Notch
receptors contain up to 36 EGF repeats, some of which can be
modified with three unusual types of O-linked glycosylation:
O-fucose, O-glucose, and O-GlcNAc (4, 5). Although many proteins contain EGF repeats, the consensus sequences for both
O-fucose and O-glucose modifications are abundant and conserved in the EGF repeats of Notch proteins (4, 6). Work from
several laboratories has shown the biological importance of both
the O-fucose and O-glucose modifications on Notch (7–14).
Although glucose has long been known to exist as a biosynthetic intermediate on N-glycans, less is known about protein
O-glucosylation, where glucose is linked to the hydroxyl of a distinct serine residue in the C1 -X-S-X-P-C2 consensus amino acid
sequence of an EGF repeat (15). The glucose is added by protein
O-glucosyltransferase (Poglut) (16) and is known to be extended
to a trisaccharide (Xyl-α1,3-Xyl-α1,3-Glc) on all mammalian
16600–16605 ∣ PNAS ∣ October 4, 2011 ∣ vol. 108 ∣ no. 40

proteins where it has been found, such as Notch (4, 17, 18), coagulation factors VII and IX, protein Z, Delta-like protein, and
thrombospondin (19–21). Although Notch proteins carry many
evolutionarily conserved O-glucosylation sites (4, 6), the biological role of O-glucosylation has until recently been unknown.
We recently showed that rumi, the gene encoding Poglut, is essential for Notch signaling in Drosophila. Rumi contains a signal
peptide, a CAP10 domain, and a Lys-Asp-Glu-Leu (KDEL)-like
endoplasmic reticulum (ER) retention signal at its C terminus
(12). The CAP10 gene had been suggested to be involved in the
formation of capsule and virulence of Cryptococcus neoformans,
providing a clue that the protein may be a glycosyltransferase
(22). We showed that Rumi is a Poglut that modifies Notch.
Moreover, we found that the Poglut activity of Rumi is essential
for Notch function by analyzing a mutant allele with a point
mutation (G189E) that eliminates the enzymatic activity of Rumi
without affecting protein levels (12).
Here, we report that, of the three mammalian proteins containing CAP10 domains and ER retention signals, only the closest
homologue to Drosophila Rumi (dRumi) rescues the Notch
phenotype in rumi mutant flies in vivo and has Poglut activity
in vitro. Surprisingly, biochemical analysis of the enzymatic activity of Rumi revealed that both mammalian and dRumi transfer
xylose (Xyl) as well as glucose to some of their target EGF
repeats. Furthermore, O-xylosylation of specific Notch EGF repeats occurs on Notch proteins produced in cells, suggesting that
this modification is likely to be biologically relevant.
Results
To examine the importance of O-glucosylation for mammalian
Notch, mammalian homologues of Rumi were identified using
BLAST searches. In human and mouse genomes, three potential
homologues were identified: one with a high degree of identity
(54% identity to dRumi, also known at hCLP46/KTELC1; refs.
23 and 24), designated as Rumi, and two others (KDELC1/C2)
with lower degrees of identity but with the clear presence of a
CAP10 domain (25) (Fig. 1 A and B, and Fig. S1). All three genes
encode a signal peptide, a CAP10 domain and a KDEL-like
ER retention signal at the C terminus. Unlike Rumi, KDELC1
and KDELC2 contain a filamin-like domain (26). To examine
whether these can regulate Notch signaling in vivo, we took a
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Fig. 1. Human Rumi is the functional and biochemical homologue of
Drosophila Rumi. (A) Molecular structure of human proteins containing a
CAP10 domain. SP, signal peptide; KDEL, KDEL ER-retention signal; FLMN,
filamin-like domain. (B) Percent identity of amino acid sequences of
human Rumi, KDELC1, and KDELC2 with dRumi. (C–F) Thoraces of adult flies
harboring randomly located rumiΔ26 mutant clones. The lower panels show
close-ups of the boxes in the upper panels. The rumi Δ26 mutant clones result
in loss of sensory organs on thorax (C, dotted lines in the close-up). Simultaneous overexpression of a FLAG-tagged version of hRumi restores the lost
sensory organs in rumi Δ26 mutant clones (D). Note that the rescued sensory
organs—four of which are marked by asterisks—lose the y þ transgene on
the reciprocal 3R chromosome and are therefore yellow, as opposed to
rumi þ∕− heterozygous and rumi þ∕þ sensory organs, which look darker.
Human KDELC1–FLAG (E) or hKDELC2–FLAG (F) were not able to rescue
the phenotype (dotted lines in the close-ups). (G–J) Wings of adult flies
harboring randomly located rumi 44 mutant clones. Loss of rumi results in
the thickening of wing veins (brackets) and “Notches” of tissue loss in the
wing margin (arrowhead) (G). Only hRumi–FLAG is able to rescue these
phenotypes (compare H with I and J). All animals were raised at 30 °C after
the second instar larval stage. (K) Protein expression detected by Western
blot analysis using anti-Myc antibody in the culture media from 293T cells
transfected transiently with an empty vector control (lane 1), human Rumi
(lane 2), KDELC1 (lane 3), or KDELC2 (lane 4), all with a C-terminal Myc-His6
tag. (L) The Poglut activity in the culture media from the same cells as
Fig. 1K. The values indicate the mean  SEM.

genetic approach and asked whether any of the human homologues can rescue rumi mutant phenotypes in Drosophila. We generated transgenic Drosophila strains, which allow the expression
of a FLAG-tagged version of hRumi, hKDELC1, or hKDELC2
in Drosophila tissues. When raised at 30 °C, mitotic clones of
rumi null alleles result in the loss of sensory bristles on Drosophila
thorax and margin loss and vein expansion in Drosophila wing,
Takeuchi et al.
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consistent with loss of Notch signaling (12) (Fig. 1 C and G).
Overexpression of the human proteins in mitotic clones homozygous for rumi alleles shows that hRumi–FLAG rescues the sensory organ and wing phenotypes of rumi clones (Fig. 1 D and H).
However, neither hKDELC1–FLAG nor hKDELC2–FLAG is
able to rescue the rumi loss-of-function phenotypes (Fig. 1 E, F,
I, and J). To ensure that the lack of rescue by hKDELC1–FLAG
and hKDELC2–FLAG is not because of protein instability or
lack of expression, we performed anti-FLAG staining on third
instar Drosophila wing imaginal discs (Fig. S2 A–C). We find that
all three human proteins are expressed at relatively high levels in
the mitotic clones (Fig. S2 A′–C′). The Notch protein accumulates in mutant clones of the fly rumi (12). Antibody staining indicates that this phenotype is also rescued by hRumi–FLAG but
not by hKDELC1–FLAG or hKDELC2–FLAG (Fig. S2 A′′–C′′).
Although all three proteins were expressed and secreted into
the culture media after transient transfection in 293T cells
(Fig. 1K), only hRumi showed significant Poglut activity (Fig. 1L).
We conclude that hRumi is the only homologue which shows
biochemical and functional conservation with dRumi.
Mammalian Rumi, like dRumi, has a C-terminal KDEL-like
sequence, suggesting that it resides and functions in the ER. To
test this notion, a truncated version of mouse Rumi lacking its
KDEL-like sequence (Lys-Thr-Glu-Leu, KTEL) was expressed
in 293Tcells. Compared with wild-type, deletion of KTEL caused
a decrease in the Poglut activity in cell lysates and a significant
increase in the activity in the culture media (Fig. S3A). Furthermore, most of the endogenous Poglut activity of mammalian
cell extracts was detected in fractions from a sucrose gradient
corresponding to the ER (Fig. S3B) and was detected in soluble
fractions, but not in membrane fractions (Fig. S3C). These
results indicate that mammalian Rumi is a soluble ER-localized
protein, consistent with what is known about dRumi (12).
During our initial characterization of its biochemical activity,
we examined donor substrate specificity of Rumi using a variety
of nucleotide sugars in in vitro assays with human factor VII
(hFVII) EGF repeat as acceptor substrate. Surprisingly, we found
that both UDP-Xyl and UDP-glucose were utilized by mouse
Rumi (Fig. 2A). Because Xyl has the same orientation of hydroxyl
groups but lacks the extracyclic methoxy group of glucose, UDPXyl could conceivably fit into the same active site as UDP-glucose
(Fig. 2B). Further kinetic analysis showed that both activities of
Rumi were dependent on the amount of Rumi (Fig. 2C), and the
concentrations of hFVII EGF repeat (Fig. 2D), UDP-glucose, or
UDP-Xyl (Fig. 2E). Both Poglut (14) and protein O-xylosyltransferase activity (Poxylt) activity (Fig. S3D) decreased approximately 50% in the extracts of the neonatal livers of Rumiþ∕−
mice compared with those from wild-type mice. Furthermore, a
glycine to glutamate mutation at G169, which is thought to be
involved in binding UDP-glucose (27), made Rumi incapable of
transferring glucose as well as Xyl (Fig. 2F). A similar result was
observed with dRumi (Fig. S3E). These results suggest that Rumi
transfers both glucose and Xyl to hFVII EGF repeat and that the
dual activity of Rumi is evolutionarily conserved.
We examined the structures of the Poglut and Poxylt reaction
products extensively. The products eluted as a single peak slightly
earlier than the unglycosylated substrate on reverse phase HPLC,
suggesting that the sugars were covalently attached to the substrate and made the products more hydrophilic (Fig. S4 A–C).
Analysis by electrospray ionization-MS/MS (Fig. S4 D–F) confirmed that the product of the Poglut reaction is hFVII EGF
modified with a hexose, whereas the product of the Poxylt reaction is the EGF repeat modified with a pentose. To confirm the
sugar structure on the products, we performed in vitro reactions
using UDP-½3 Hglucose or UDP-½14 CXyl and purified the radioactive ½3 Hglucosylated- or ½14 Cxylosylated-hFVII EGF repeats
by reverse phase HPLC (Fig. S4G). The O-glycans were released
from the purified products by alkali-induced β-elimination and
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Fig. 2. Rumi has Poxylt activity as well as Poglut activity. (A) Donor substrate
specificity of N-terminal His-tagged mouse Rumi (His-mRumi). A representative dataset from two independent assays is shown. (B) Structure of UDPglucose and UDP-Xyl. (C) Enzyme dependence of Poglut (blue) or Poxylt
(red) activities of His-mRumi toward hFVII EGF repeats (5 μM). (D) EGF dependence of Poglut (blue) or Poxylt (red) activities of His-mRumi in the presence
of 10 μM UDP-sugars. Note, kinetic parameters were calculated using the
data points below 5 μM of EGF repeats by Lineweaver–Burk plot because
the decreased activities at higher range may be due to substrate inhibition.
(E) UDP-sugar dependence of Poglut (blue) or Poxylt (red) activities of
His-mRumi toward hFVII EGF repeats (5 μM). (F) Poglut (blue) or Poxylt (red)
activities of FLAG-tagged versions of wild-type or G169E mutant hRumi
toward hFVII EGF repeats (5 μM). The values indicate mean  SEM.

subjected to gel filtration chromatography, where they migrated
at a size consistent with a monosaccharide (Fig. S4H). High-pH
anion exchange chromatography coupled with pulsed amperometric detection analysis (Fig. S4I) demonstrated that the Poglut
product is glucitol and the Poxylt product is xylitol, the theoretical
products from O-glucosylated or O-xylosylated EGF repeats
after alkali-induced β-elimination, respectively. NMR analysis of
glucosylated or xylosylated human factor IX (hFIX) EGF repeats
synthesized with hRumi in vitro confirmed the product identification and clearly showed that the anomericity of both O-glucose
and O-Xyl is beta (Fig. S5). These results indicate that Rumi
transfers a single O-glucose or O-Xyl monosaccharide to EGF
repeats in a β-linkage.
To examine whether O-Xyl is added to the O-glucose consensus site of the EGF repeats, we performed the glycosyltransferase
assays using the hFVII EGF repeats, which had been modified
with prior addition of O-fucose by protein O-fucosyltransferase
1 (Pofut1) (28), O-glucose, or O-Xyl by Rumi (Fig. 3A). Pofut1
added O-fucose to O-glucosylated, O-xylosylated, or unmodified
EGF repeats, but not to O-fucosylated EGF, whereas Rumi could
add Xyl or glucose to either unmodified or O-fucosylated EGF
16602 ∣

Poxylt activity (Rumi)

FVII (WT)
FVII (S53A)

30

www.pnas.org/cgi/doi/10.1073/pnas.1109696108

Poglut activity

40

40

0

B 50

Poglut activity (Rumi)

Fuc-EGF Glc-EGF Xyl-EGF

Relative Abundance

Specific activity toward FVII EGF
[nmol/(min·mg)]

E

GDP- UDP- UDP- UDP- UDP- UDP- GDP- UDPFuc Gal GalNAc Glc GlcA GlcNAc Man Xyl
Specific activity toward FVII EGF
[nmol/(min·mg)]

Specific activity toward FVII EGF
(pmol/min)

C

0

80
60
40
20
0
80
60
40
20
0
8
6
4
2
0

Specific activity [nmol/(min·mg)

Rumi

40

Specific activity [nmol/(min·mg)]

A

B

Specific activity toward hFVII EGF
[nmol/(min·mg)]

Specific activity [nmol/(min·mg)]

A 50

EGF
FVII (S52A)
FIX

30
20
10
0
0
50

2

4
6 8
EGF (µM)

10

Poxylt activity

40
30
20
10
0
0

2

4 6 8
EGF (µM)

10

MDGDQCASSPCQNGGSCK

1,182.4
y11

13 12 11 10 9 8 7 6 5 4 3 2 1

80
1,253.4
60
y12
1,413.5
40
y13
20
0
(ii) +O-Glucose
M D G D Q C A S S P C Q N G G S C K+Glucose (Hex)
1,182.4
13 12 11 10 9 8 7 6 5 4 3 2 1
100 1,095.4
y10
y11 No y10+Hex at 1,257.4 m/z
80
1,253.4 y11+Hex
y13+Hex
y12+Hex
60
1,413.5 1,415.4
y12 1,344.4
1,575.5
y13
40
20
0
(iii) +O-Xylose
M D G D Q C A S S P C Q N G G S C K+Xylose (Pen)
1,182.4
13 12 11 10 9 8 7 6 5 4 3 2 1
1,095.4
100 y10
y11 No y10+Pen at 1,227.4 m/z
80
y11+Pen y12+Pen
y13+Pen
1,253.4
60
1,385.5 1,413.5
1,314.4
1,545.5
y12
y13
40
20
0
1,100 1,150 1,200 1,250 1,300 1,350 1,400 1,450 1,500 1,550 1,600
m/z

Fig. 3. The diserine motif in the O-glucose consensus sequence is an indicator for O-Xyl transfer by Rumi. (A) Poglut (Top) or Poxylt activity (Middle) of
His-mRumi, or Pofut1 activity of human Pofut1 toward hFVII EGF repeats
modified with O-fucose (Fuc-EGF), O-glucose (Glc-EGF), O-xylose (Xyl-EGF),
or unmodified hFVII EGF repeats (5 μM). Data are representative of two independent assays. (B) EGF dependence of Poglut (Upper) or Poxylt (Lower)
activity of hRumi–FLAG toward hFVII EGF repeat (WT, blue), S52A (red), or
S53A (green) mutants, and hFIX EGF repeat (purple). The values indicate
mean  SEM. (C) HCD analysis after trypsin digestion of the hFVII EGF repeats
unmodified or modified with O-glucose or O-Xyl by hRumi. Collision-induced
dissociation fragmentation confirmed the identity of the peptide and the
modifications (Fig. S6). (i) HCD fragmentation of the doubly charged form
of the peptide MDGDQCASSPCQDGGSCK (m/z 980.3) from unmodified
hFVII EGF repeats. Numerous sequence fragment y ions are observed that
confirm the identity of the peptide. (ii) HCD fragmentation of the doubly
charged form of the O-glucosylated peptide (m/z 1,061.3) from O-glucosylated hFVII EGF repeats. Numerous sequence fragment y ions are observed
that not only confirm the identity of the peptide, but also the attachment
of a hexose (glucose) to the first serine within the diserine motif. Although
y10 þ Hex (m/z 1,257.4) was not detected, y11 þ Hex (m/z 1,344.4), y12 þ Hex
(m/z 1,415.4), and y13 þ Hex (m/z 1,575.5) ions were detected, confirming the
attachment of hexose to the first serine. (iii) HCD fragmentation of the doubly charged form of the O-xylosylated peptide (m/z 1,046.3) from O-xylosylated hFVII EGF repeats. Numerous sequence fragment y ions are observed
that not only confirm the identity of the peptide, but also the attachment
of a pentose (xylose) to the first serine within the diserine motif. Although
y10 þ Pen (m/z 1,227.4) was not detected, y11 þ Pen (m/z 1,314.4), y12 þ Pen
(m/z 1,385.5), and y13 þ Pen (m/z 1,545.5) ions were detected.

repeat. These results suggest that the O-fucose site is distinct
from both the O-glucose and O-Xyl sites on the EGF repeat. In
contrast, neither O-glucosylated nor O-xylosylated EGF repeats
served as acceptor for addition of O-Xyl or O-glucose by Rumi,
suggesting that these modifications occur at the same site.
Although the hFVII EGF repeat is known to be O-glucosylated at
serine 52 (20), it contains a second serine residue (serine 53) in the
O-glucose consensus sequence (50 CASSPC55 ). To examine which
serine is the attachment site for O-Xyl, we used EGF repeats in
Takeuchi et al.
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Fig. 4. O-Xyl trisaccharide on EGF16 of mNotch2 is dependent on the
diserine motif. Extracted ion chromatograms (EICs) of the ions corresponding
to (glyco)peptides containing the O-glucose consensus sequence from EGF16
of mNotch2 derived from Asp-N digests of wild-type (A) or the mutated
(B) mNotch2 proteins (see Fig. S8 for mass spectra confirming the identity
of these ions). (A) EICs of the ions corresponding to the unglycosylated
(Top), O-glucosylated (Middle), and O-xylosylated (Bottom) forms of
582 DQIDECYSSPCLN594 from wild-type mNotch2 EGF16. The MS data were
searched for the doubly charged form of these (glyco)peptides: m/z 801.0
for the unglycosylated, m/z 1,014.0 for the O-glucosylated, and m/z 999.0
for the O-xylosylated forms. (B) EICs of the ions corresponding to the unglycosylated (Top), O-glucosylated (Middle), and O-xylosylated (Bottom) forms
of 582 DQIDECYSAPCLN594 from the mutated mNotch2 EGF16. The MS data
were searched for the doubly charged form of these (glyco)peptides: m/z
793.0 for the unglycosylated (Top), m/z 1,006.0 for the O-glucosylated
(Middle), and m/z 991.0 for the O-xylosylated (Bottom) forms.

within Notch can be modified by O-Xyl or O-glucose in cells (with
endogenous levels of UDP-glucose and UDP-Xyl), and that the
diserine motif appears to be an indicator for where Xyl modifications may occur.
Discussion
Mammalian CAP10-Like Genes. Recently, we identified dRumi as an

essential component for Notch signaling in flies and showed that
dRumi is a Poglut (12). In the present study, we analyzed three
candidate mammalian genes as dRumi homologues and showed
that mammalian Rumi has Poxylt activity as well as Poglut activity, whereas the other two homologues, KDELC1 and KDELC2,
have neither of those activities. Furthermore, mammalian Rumi
rescues defects in Notch signaling in rumi clones, indicating that
mammalian Rumi can regulate Notch signaling in vivo. Loss of one
copy of the Rumi gene reduced approximately 50% of both Poglut
and Poxylt activities in neonatal mouse livers (14) (Fig. S3D). Together, these results strongly suggest that Rumi is the only Poglut/
Poxylt for EGF repeats in mammals.
PNAS ∣ October 4, 2011 ∣
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which Ser52 or Ser53 were mutated to Ala (S52A or S53A). Our
prior studies using crude cell extracts as enzyme source showed
that O-glucose is added to the S53A mutant, but not to the S52A
mutant, consistent with the predicted modification site (16). As
expected, purified Rumi was not able to glucosylate the S52A
mutant, but the S53A mutant was still an excellent acceptor substrate (even slightly better than wild type), confirming that Rumi
transfers O-glucose only to the predicted site, Ser52 (Fig. 3B). Similarly, the Poxylt activity of Rumi was completely lost with the
S52A mutant, suggesting Ser52 is the site of modification. Interestingly, we detected a dramatic decrease in Poxylt activity of Rumi
toward the S53A mutant compared with the wild type (Fig. 3B).
This result suggests that either both Ser52 and Ser53 are modified
with O-Xyl, or Ser53 is important for O-xylosylation at Ser52. To
differentiate between these possibilities, we examined the specific
amino acid modified using mass spectrometry. Collision-induced
dissociation fragmentation of tryptic peptides from glucosylated
or xylosylated EGF repeats confirmed the attachment of hexose
or pentose, respectively, to the peptide containing the consensus
sequence (MDGDQCAS52 S53 PCQNGGSCK) (Fig. S6). Higherenergy C-trap dissociation (HCD) analysis showed that both
O-glucose and O-Xyl are attached to Ser52 (Fig. 3C). These results
suggest that, unlike the Poglut activity that modifies the consensus
motif regardless of the identity of the X amino acids surrounding
the S, the Poxylt activity of Rumi is sensitive to the flanking amino
acid sequences, and that the Ser residue next to the O-glucose site
facilitates O-xylosylation.
To examine the importance of the diserine motif in more detail,
we used the hFIX EGF repeat as acceptor substrate. Factor IX is
known to be modified by O-glucose (20), but lacks the second
serine within the O-glucose consensus sequence (51 CESNPC56 ).
Interestingly, although hFIX EGF repeats can be both O-glucosylated and O-xylosylated by Rumi, it is a poor acceptor substrate for
O-Xyl transfer, similar to the hFVII S53A mutant (Fig. 3B). These
results confirm that the presence of the diserine motif significantly
promotes the transfer of Xyl to EGF repeats by Rumi.
To examine whether O-Xyl exists on EGF repeats produced in
cells, we examined the glycosylation of EGF16 from mouse
Notch2 (mNotch2), which also contains a diserine motif within
an O-glucose consensus sequence (587 CYSSPC592 ). Initially we
confirmed that Rumi could add O-glucose or O-Xyl to the first
serine within the motif of bacterially expressed mNotch2 EGF16
in vitro (Fig. S7). To determine whether O-Xyl occurs on EGF16
produced in cells, we performed mass spectral analysis of the peptide containing the consensus sequence resulting from Asp-N
digestion of EGF13–18 from mNotch2 expressed in 293T cells:
582
DQIDECYSSPCLN594 . Interestingly, we observed both an
O-pentose trisaccharide and a canonical O-glucose-pentose-pentose trisaccharide on this peptide (Fig. 4A and Fig. S8). Extracted
ion chromatograms of the ions corresponding to the unmodified,
O-glucose trisaccharide, and O-pentose trisaccharide forms of
this peptide are shown in Fig. 4A. Assuming that both glycoforms
of the peptide ionize to the same degree, the O-pentose trisaccharide form appears to be present at approximately 5% of the
level of the O-glucose trisaccharide form. This ratio is consistent
with what is known about relative levels of UDP-glucose and
UDP-Xyl within cells (17), although it could change in a celldependent manner because nucleotide sugar levels are known to
vary from cell to cell (29). O-glucose-pentose-pentose trisaccharide has been detected on several other peptides corresponding to
O-glucose motifs on other EGF repeats derived from EGF13–18
of mNotch2 (14). However, we have not found evidence for
O-pentose trisaccharide at any of these other sites, none of which
contain the diserine motif. When the second serine residue in the
EGF16 site was mutated to Ala (587 CYSAPC592 ), only the peptide modified with O-glucose trisaccharide was detected (the
O-pentose form and unmodified form could not be detected,
Fig. 4B and Fig. S8). These results demonstrate that EGF repeats

The molecular function(s) of KDELC1 and KDELC2 is still
unknown. We have shown that the CAP10 domain of dRumi
has two DXD-like motifs and that the latter one is functionally
important in vitro and in vivo (12, 30). Mammalian Rumi also has
two DXD-like motifs in the CAP10 domain, but KDELC1 and
KDELC2 do not have the latter one (Fig. S1). Moreover, both
dRumi and hRumi have a WXGG motif which is essential for
their enzymatic activity (12, 14) (Fig. 2 and Fig. S3) and is implicated in interaction with UDP-sugar donors (27). However,
KDELC1 and KDELC2 lack this motif (Fig. S1). Unlike Rumi,
KDELC1 and KDELC2 have a filamin-like domain which is
known to be involved in interaction with other molecules such
as Actin (26) (Fig. 1). To examine the potential roles of modulation of O-glucosylation and/or O-xylosylation through interaction
with Rumi, we performed the glycosyltransferase assays with
Rumi in the presence of the purified KDELC1 or KDELC2.
Neither KDELC1 nor KDELC2 affected the dual activities of
Rumi. Thus, further work is needed to determine the biochemical
function of KDELC1 and KDELC2.
How Does Rumi Recognize Donor Substrates? Surprisingly, Rumi
utilized UDP-glucose and UDP-Xyl with almost the same affinity
(Fig. 2E), but not UDP-glucuronic acid. The only structural difference between UDP-glucose, UDP-Xyl, and UDP-glucuronic acid is
at the C6 position of the sugar (Fig. 2B). The larger, charged C6
group of UDP-glucuronic acid probably precludes significant
binding to the active site, but the lack of a C6 group in UDP-Xyl
must allow binding. O-glucose and O-Xyl are β-linked to the serine
in EGF repeats (18, 21) (Fig. S5), but are in an α-linkage in UDPglucose and UDP-Xyl, suggesting that Rumi is an inverting enzyme. Because a point mutation at G169 abrogated both Poglut
and Poxylt activities of Rumi, Rumi is likely to use the same active
site to transfer O-glucose and O-Xyl to EGF repeats.
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How Does Rumi Recognize Acceptor Substrates? Rumi only modifies

properly folded EGF repeats containing the O-glucose consensus
sequences (C1 -X-S-X-P-C2 ) and does not transfer glucose or Xyl
to EGF repeats in which this serine (S) is mutated to alanine
(Fig. 3). Surprisingly, efficient transfer of Xyl (but not glucose)
required the presence of a second serine, C1 -X-S-S-P-C2 . This
result suggests that the specificity of the enzyme for the donor
substrate is influenced by the structure of the acceptor. It is
known that single amino acid mutations in the active sites of some
glycosyltransferases can alter their donor substrate specificity
such as β4Gal-T and GlcAT-I (31), but altering donor substrate
specificity by changes in acceptor substrate is highly unusual.
Although structural work will need to be done to fully explain
this observation, it suggests that the nucleotide sugar binds at the
interface between the enzyme and the EGF repeat, and that
sequences within the EGF repeat modulate the affinity of the tertiary complex. We have seen differential efficiency of O-glucosylation among the Notch EGF repeats containing the O-glucose
consensus sequences (14), which is most likely due to the differences in the amino acid sequence of the EGF repeats. Interestingly, among the EGF repeats examined in the EGF13–18 of
mNotch2, EGF16 is the only one which has this diserine motif
(587 CYSSPC592 ) and the only one which is modified with O-Xyl
glycans. Database searches reveal the presence of a number of
other EGF repeats with a diserine motif in other potential Rumi
targets such as mNotch1, mNotch3, Delta-like1, Crumbs1, and
Regeneration-associated muscle protease. We are currently examining the glycosylation status of those proteins.
What Does the Dual Specificity of Rumi Mean Biologically? The
G189E missense mutation in dRumi and its equivalent G169E
mutation in the mammalian Rumi abolish the enzymatic activity
of the Rumi proteins without affecting their expression level or
stability. The G189E mutation results in temperature-sensitive
16604 ∣
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loss of Notch signaling in flies, similar to null alleles of rumi
(12). Moreover, our recent study shows that the G169E mutant
fails to rescue the Notch-dependent neurite outgrowth phenotypes caused by Rumi knockdown in the Neuro2A mouse neuroblastoma cells (14). These results indicate that Rumi primarily
regulates Notch signaling through its enzymatic activity. Based
on the ability of Rumi to function both as a Poglut and as a Poxylt,
and also given the presence of both of these carbohydrates on
Notch EGF repeats, we propose that regulation of Notch signaling by Rumi depends on the addition of O-glucose or O-Xyl to
Notch pathway components by Rumi.
Our results indicate that in some EGF repeats, O-Xyl glycans
are attached to the serine residue in the C1 -X-S-X-P-C2 consensus sites, which was previously thought to be exclusively modified
by O-glucose (Fig. S9). We found O-pentose trisaccharides on
mNotch2. Because Xyl is the only pentose known to modify proteins in mammals, the O-pentose trisaccharide is most likely an
O-Xyl elongated with two Xyls (e.g., Xyl-α1,3-Xyl-α1,3-Xyl-βOSer). If the α1,3-xylosyltransferases that extend the O-Xyl were
down-regulated in a tissue, the β-linked O-Xyl could serve as a
primer for glycosaminoglycan biosynthesis. Analysis of data from
EST databases suggests that the α1,3-xylosyltransferases are
indeed expressed in tissue-specific, developmentally regulated
patterns, suggesting that, in certain tissues with low levels of these
enzymes, the β-linked O-Xyl monosaccharides are exposed and
therefore glycosaminoglycan addition may be favored (Fig. S9).
Interestingly, Kamimura et al. showed that heparan sulfate
3-O-sulfotransferase regulates Notch signaling in Drosophila (32),
suggesting that glycosaminoglycans might be involved in Notch
pathway regulation.
Experimental Procedures
Materials. A cell line, called 293T cells, from the American Type

Culture Collection were grown in Dulbecco’s modified Eagle’s
medium (Invitrogen) supplemented with 10% fetal bovine serum.
GDP-½3 Hfucose, UDP-½3 Hgalactose, UDP-½3 H N-acetylgalactosamine, UDP-½3 Hglucose, UDP-½3 Hglucuronic acid, UDP-½3 H
N-acetylglucosamine, and UDP-½14 CXyl were purchased from
American Radiolabeled Chemicals. GDP-½3 Hmannose was a kind
gift from Neta Dean (Stony Brook University). UDP-α-D-Xyl was
purchased from Complex Carbohydrate Research Center at the
University of Georgia. All other reagents were of the highest quality available.
Constructs for Expression of Mammalian Rumi, KDELC1, and KDELC2.

The cDNAs of human Rumi, KDELC1, and KDELC2 were purchased from Open Biosystems and their ORFs were inserted into
pcDNA4/TO/myc-His vector so that the recombinant proteins
were expressed with a C-terminal myc-His6 tag. FLAG-tagged
version of wild-type and G169E mutant human Rumi was constructed in pTracer vector (14). The cDNA of mouse Rumi was
purchased from RIKEN and inserted into pcDNA4/TO/myc-His
vector. The His6 tag sequence was inserted immediately after the
signal peptide. DNA sequences of the constructs were confirmed
by sequencing. All the primers are available upon request.
Purification of the His6 - or FLAG-Tagged Proteins by Ni-Nitrilotriacetate Chromatography. His6 -tagged Rumi proteins or EGF13–18 of

mouse Notch2 from 293T cells transfected with the expression
vectors were purified as described in ref. 33. FLAG-tagged version of human Rumi (wild type and G169E mutant) was purified
as described in ref. 12. Protein concentration was determined by
Coomassie staining using BSA as a standard.

Poglut/Poxylt Assay. Poglut assays were performed as previously
described (12, 16). A 10-μL reaction mixture contained 50 mM
Hepes (pH 7.0), 10 mM MnCl2 , the indicated amounts of acceptor substrates (e.g., hFVII EGF repeats), 0.16 μM (0.01 mCi∕ml;
Takeuchi et al.
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1 Ci ¼ 37 GBq) UDP-½3 Hglucose, 10 μM UDP-glucose, 0.5%
Nonidet P40, and purified proteins. For Poxylt assay, 10 μM
UDP-½14 CXyl was used as donor substrate. The reaction was
performed at 37 °C for 20 min and stopped by adding 900 μL
of 100 mM EDTA (pH 8.0). The sample was loaded onto a C18
cartridge (100 mg, Agilent). After the cartridge was washed with
5 mL of H2 O, the EGF repeat was eluted with 1 mL of 80%
methanol. Incorporation of ½3 Hglucose or ½14 CXyl into the EGF
repeats was determined by scintillation counting of the eluate.
Reactions without substrates were used as background control.
The mouse and human proteins are very similar biochemically.
Most biochemical analyses shown in the manuscript were done
using both mouse and human Rumi proteins but due to space
limitations, only the mouse Rumi data are shown. Some data
using human Rumi (Fig. 2F and Fig. 3B) are included to demonstrate the biochemical similarity.

Mass Spectrometric Analysis. Notch proteins purified by Ni-nitrilotriacetate affinity chromatography were reduced, alkylated,
digested with Asp-N protease (Sigma), and analyzed by nanoliquid chromatography/tandem mass spectrometry using an Agilent 6340 ion-trap mass spectrometer with a nano-HPLC CHIPcube interface auto sampler as reported previously (34, 35). HCD
analysis was performed at Stony Brook University Proteomics
Center using LTQ Orbitrap from Thermo Fisher Scientific (36).
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